We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RPAI
301
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $8.97M | 0.06% |
559,360
+40,063
| +8% | +$671K |
|
302
Kulicke & Soffa
KLIC
$4.78B
| $8.82M | 0.05% |
564,102
+199,718
| +55% | +$3.1M |
|
|
BDN
303
Brandywine Realty Trust
BDN
$554M
| $8.81M | 0.05% |
551,335
-563,012
| -51% | -$9.06M |
|
304
Telecom Argentina
TEO
$5.96B
| $8.79M | 0.05% |
387,231
+8,718
| +2% | +$188K |
|
305
Asbury Automotive
ABG
$3.85B
| $8.78M | 0.05% |
105,651
-15,932
| -13% | -$1.23M |
|
|
306
AstraZeneca
AZN
$250B
| $8.62M | 0.05% |
126,006
-4,420,009
| -97% | -$307M |
|
307
Lands' End
LE
$403M
| $8.55M | 0.05% |
238,234
+100,960
| +74% | +$4.01M |
|
308
Employers Holdings
EIG
$889M
| $8.48M | 0.05% |
314,039
+33,696
| +12% | +$790K |
|
309
L3Harris
LHX
$53.4B
| $8.41M | 0.05% |
106,813
+65,313
| +157% | +$4.76M |
|
|
CPN
310
DELISTED
Calpine Corporation
CPN
| $8.41M | 0.05% |
367,630
+313,697
| +582% | +$6.76M |
|
311
Ball Corp
BALL
$16.8B
| $8.4M | 0.05% |
+237,736
| New | +$8.23M |
|
|
AVP
312
DELISTED
Avon Products, Inc.
AVP
| $8.39M | 0.05% |
+1,049,851
| New | +$8.72M |
|
313
Acadia Realty Trust
AKR
$2.84B
| $8.34M | 0.05% |
239,028
+22,895
| +11% | +$797K |
|
|
FSP
314
Franklin Street Properties
FSP
$46.8M
| $8.31M | 0.05% |
648,081
-89,890
| -12% | -$1.15M |
|
315
Keurig Dr Pepper
KDP
$40.8B
| $8.27M | 0.05% |
+105,405
| New | +$8.15M |
|
316
Pampa Energía
PAM
$4.41B
| $8.26M | 0.05% |
467,338
-18,960
| -4% | -$250K |
|
|
DEG
317
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
| $8.21M | 0.05% |
366,771
-63,614
| -15% | -$1.35M |
|
318
New York Times
NYT
$10.2B
| $8.12M | 0.05% |
589,983
-18,736
| -3% | -$251K |
|
|
IDTI
319
DELISTED
Integrated Device Technology I
IDTI
| $8.05M | 0.05% |
+401,908
| New | +$7.91M |
|
320
Crown Holdings
CCK
$13.1B
| $7.98M | 0.05% |
147,673
+143,535
| +3,469% | +$7.13M |
|
321
ON Semiconductor
ON
$31.6B
| $7.88M | 0.05% |
650,725
-1,950,388
| -75% | -$22.3M |
|
322
Moog Inc Class A
MOG.A
$12.8B
| $7.86M | 0.05% |
104,732
| – | – |
|
|
AMSG
323
DELISTED
Amsurg Corp
AMSG
| $7.81M | 0.05% |
126,999
-412,753
| -76% | -$23.8M |
|
|
LUX
324
DELISTED
Luxottica Group
LUX
| $7.75M | 0.05% |
123,567
+99,627
| +416% | +$5.94M |
|
325
DexCom
DXCM
$32B
| $7.74M | 0.05% |
496,700
+476,128
| +2,314% | +$7.19M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.